Your browser doesn't support javascript.
Pediatric influenza vaccination rates lower than previous estimates in the United States.
Gates, Dana M; Cohen, Steven A; Orr, Kelly; Caffrey, Aisling R.
  • Gates DM; College of Pharmacy, University of Rhode Island, Kingston, RI, United States.
  • Cohen SA; Department of Health Studies, College of Health Sciences, University of Rhode Island, Kingston, RI, United States.
  • Orr K; College of Pharmacy, University of Rhode Island, Kingston, RI, United States.
  • Caffrey AR; College of Pharmacy, University of Rhode Island, Kingston, RI, United States; Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States; Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, R
Vaccine ; 40(44): 6337-6343, 2022 Oct 19.
Article in English | MEDLINE | ID: covidwho-2042192
ABSTRACT

BACKGROUND:

Annually, pediatric influenza vaccination coverage estimates are ascertained from health surveys, such as the National Immunization Survey (NIS-Flu). From 2010 to 2017, vaccination coverage among children ranged from 51 to 59 %. Recognizing the limitations of national health survey data, we sought to describe temporal trends in pediatric influenza vaccination coverage, and demographic differences among a commercially insured large national cohort from 07/01/2010 to 06/30/2017.

METHODS:

Influenza vaccination coverage was assessed among children (<18 years) with continuous enrollment in the de-identified Optum Clinformatics® Data Mart database, and from NIS-Flu. Time trends in vaccination coverage were assessed using Joinpoint regression, overall and stratified by age group, sex, and geographic region.

RESULTS:

The average annual pediatric influenza vaccination coverage was 33.4 % in our study population versus 56.5 % reported from NIS-Flu during the same period (p-value < 0.0001). Vaccination coverage was highest in children 6 months-4-years old at 52.6 % (versus 68.8 % NIS-Flu, p-value < 0.0001), and lowest in the 13-17-year-old age group at 20.1 % (versus 42.8 % NIS-Flu, p-value < 0.0001). Vaccination coverage over time remained stable in our study population (average annual percent change 1.8 %, 95 % confidence interval [CI] -2.3 % to 6.0 %) versus significantly increasing by 2.8 % in NIS-Flu (95 % CI 0.3 % to 5.3 %).

CONCLUSIONS:

Vaccination coverage in our commercially insured pediatric population was 51.4% lower than estimates from NIS-Flu during the same period, suggesting the need for more accurate vaccination coverage surveillance, which will also be critical in future COVID-19 vaccination efforts. Effective interventions are needed to increase pediatric influenza vaccination rates to the Healthy People 2020 target of 70%.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Child / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2022 Document Type: Article Affiliation country: J.vaccine.2022.09.053

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Child / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2022 Document Type: Article Affiliation country: J.vaccine.2022.09.053